Literature, news and videos pertinent to
The Steven Braunstein
Molecular Early Detection Program
Check Out Pancreatic Cancer News Developments
- Discovering the anticancer potential of non-oncology drugs by systematic viability profiling
Corsello, S.M., Nagari, R.T., Spangler, R.D. et al. Discovering the anticancer potential of non-oncology drugs by systematic viability profiling. Nat Cancer (2020) doi:10.1038/s43018-019-0018-6 - The Basic Helix-Loop-Helix Transcription Factor E47 Reprograms Human Pancreatic Cancer Cells to a Quiescent Acinar State With Reduced Tumorigenic Potential.
- Imaging for Pancreatic Cancer
- Chemotherapy Advisor Endocrine Cancer Resource Center
- Tiny capsule effectively kills cancer cells
- Life-Saving DNA Test Overlooked in Rise of Colon Cancer
- Md. High School Freshman Creates Test To Detect Pancreatic Cancer
- Clinical Trials - Pancreatic Cancer
- Slowing pancreatic cancer
powered by Surfing Waves
The Steven Braunstein
Molecular Early Detection Program
is a vital part of ICAN's Cancer Patient Advocacy and Clinical Trials Program Advocacy Services.
For more information about this special program, please click on...
Federal Tax I.D.: EIN 86-0818253